Serum Ferritin and Prognosis of DKA

Launched by SOHAG UNIVERSITY · Dec 21, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at how serum ferritin levels, which is a protein that helps store iron in the body, relate to diabetic ketoacidosis (DKA) in patients. DKA is a serious condition that can occur in people with diabetes when their blood sugar levels get very high. The researchers want to see if the amount of ferritin in the blood can help understand how severe the DKA is when patients first come to the hospital and if it can predict how they might do in the short term after treatment.

To participate in this study, patients need to be 18 years or older and have either type 1 or type 2 diabetes with a confirmed diagnosis of DKA. However, certain individuals won't be eligible, such as those under 18, those with specific blood disorders or chronic infections, and patients with other serious health conditions like heart disease or cancer. If someone is eligible and joins the trial, they can expect to have their ferritin levels tested along with other routine evaluations to see how these levels relate to their DKA symptoms and recovery. This study is not yet recruiting participants, but it aims to provide valuable insights into managing DKA better.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • -
• All patients with DKA :
• • 1. Adult Aged 18 years old or older .
• • 2. Type 1 DM , type 2 DM
• • 3. Diagnosis of DKA based on the American Diabetes Association criteria: blood glucose \>250 mg/dL, arterial pH \<7.3, serum bicarbonate \<18 mEq/L,
• Exclusion Criteria:
• • 1. Patients age less than 18 years old
• • 2. Iron deficiency anemia and iron overload
• • 3. Chronic Inflammatory Diseases: Conditions such as rheumatoid arthritis, systemic lupus erythematosus, and inflammatory bowel disease
• • 4. Acute and chronic infections, including bacterial, viral, and fungal infections
• • 5. Pt presented with other acute complication (MI,stroke)
• • 6. CKD patients
• • 7. Patients with chronic liver diseases
• • 8. Patients with malignancy
• • 9. Pregnant women.